Inflammation-Controlling Sepsis Treatment Results in Improved Patient Outcomes

Dziedzic, Jessica
October 2007
Pulmonary Reviews;Oct2007, Vol. 12 Issue 10, p35
The article discusses research being done on the influence of early hemodynamic optimization and biomarker patterns of severe sepsis and septic shock. It references a study by Emanuel P. Rivers and colleagues published in the September 2007 issue of "Critical Care Medicine." The study suggests that early goal-directed therapy can alter biomarker responses in patient presenting with early severe sepsis. The patterns identified were associated with improved global tissue hypoxia, organ dysfunction and mortality.


Related Articles

  • Biomarkers of Sepsis. Sung-Yeon Cho; Jung-Hyun Choi // Infection & Chemotherapy;Mar2014, Vol. 46 Issue 1, p1 

    Sepsis remains a leading cause of death in critically ill patients, despite efforts to improve patient outcome. Thus far, no magic drugs exist for severe sepsis and septic shock. Instead, early diagnosis and prompt initial management such as early goal-directed therapy are key to improve sepsis...

  • Oportunitatea administrării dozelor substitutive de cortizon la pacienÈ›ii cu ÅŸoc septic. MIREA, LILIANA; GRINȚESCU, IOANA; DUMITRACHE, CONSTANTIN // Romanian Journal of Medical Practice;2013, Vol. 8 Issue 2, p74 

    Severe sepsis and septic shock are currently among the most common causes of morbidity and mortality in intensive care, diagnosis may be problematic because of atypical or unspecific presentations, biomarkers are of little help at the start of treatment and are unspecific. Relative adrenal...

  • Central venous oxygen saturation in septic shock - a marker of cardiac output, microvascular shunting and/or dysoxia? Haase, Nicolai; Perner, Anders // Critical Care;2011, Vol. 15 Issue 4, p1 

    Shock therapy aims at increasing central venous oxygen saturation (ScvO2), which is a marker of inadequate oxygen delivery. In this issue of Critical Care, Textoris and colleagues challenge this notion by reporting that high levels of ScvO2 are associated with mortality in patients with septic...

  • Cardiorenal Syndromes and Sepsis. Chelazzi, C.; Villa, G.; De Gaudio, A. R. // International Journal of Nephrology;2011, p1 

    The cardiorenal syndrome is a clinical and pathophysiological entity defined as the concomitant presence of renal and cardiovascular dysfunction. In patients with severe sepsis and septic shock, acute cardiovascular, and renal derangements are common, that is, the septic cardiorenal syndrome....

  • Microalbuminuria: A novel biomarker of sepsis. Basu, Surupa; Bhattacharya, Mahuya; Chatterjee, Tapan K.; Chaudhuri, Subimal; Todi, Subhash K.; Majumdar, Arghya // Indian Journal of Critical Care Medicine;Jan-Mar2010, Vol. 14 Issue 1, p22 

    Context: Diffused endothelial dysfunction in sepsis leads to an increase in systemic capillary permeability, the renal component manifesting as microalbuminuria. The degree of microalbuminuria correlates with the severity of the acute insult, the quantifi cation of which may serve to predict...

  • Recent Advances in Sepsis Research: Novel Biomarkers and Therapeutic Targets. Iv�dy, B.; B�res, B. J.; Szab�, D. // Current Medicinal Chemistry;Jul2011, Vol. 18 Issue 21, p3211 

    No abstract available.

  • Procalcitonin as a Prognosis Marker for the Severe Sepsis and Septic Shock Patients in Emergency Department. Seung Woon Choi; Hoon Kim; Kyung Hwan Kim; Dong Wun Shin; Jun Seok Park; Jun Young Roh; Jun Min Park // Korean Journal of Critical Care Medicine;2011, Vol. 26 Issue 4, p250 

    Background: Advance in sepsis management has increased the survival of patients with sepsis. However, severe sepsis and septic shock patients still have high mortality. We intend to verify the use of the procalcitonin (PCT) level as a prognosis marker in patients with severe sepsis or septic...

  • Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail. Ruiz-Rodríguez, Juan Carlos; Rello, Jordi // Critical Care;2013, Vol. 17 Issue 5, p1 

    Procalcitonin has been proposed as a specific biomarker of bacterial infections and has been related to the severity of sepsis. The prognostic ability of the initial concentrations of procalcitonin in sepsis is controversial. Some studies find higher initial concentrations in non-survivors but...

  • Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Guisset, Olivier; Dilhuydy, Marie-Sarah; Thiébaut, Rodolphe; Lefèvre, Jérôme; Camou, Fabrice; Sarrat, Anne; Gabinski, Claude; Moreau, Jean-Fran+ACYAIw-x00E7;ois; Blanco, Patrick; Thiébaut, Rodolphe; Lefèvre, Jérôme; Moreau, Jean-François // Intensive Care Medicine;Jan2007, Vol. 33 Issue 1, p148 

    Objective: Biomarkers allowing accurate early staging of septic shock patients are lacking despite their obvious interest for patient management. Experimental models of septic shock in mouse previously noted a decrease in dendritic cell numbers. The aim of the study was to find a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics